Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

817 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Human leukocyte antigen class I and II haplotypes and risk of cervical cancer.
Carreon JD, Martin MP, Hildesheim A, Gao X, Schiffman M, Herrero R, Bratti MC, Sherman ME, Zaino RJ, Carrington M, Wang SS. Carreon JD, et al. Among authors: carrington m. Tissue Antigens. 2005 Oct;66(4):321-4. doi: 10.1111/j.1399-0039.2005.00478.x. Tissue Antigens. 2005. PMID: 16185329
Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology.
Tsukui T, Hildesheim A, Schiffman MH, Lucci J 3rd, Contois D, Lawler P, Rush BB, Lorincz AT, Corrigan A, Burk RD, Qu W, Marshall MA, Mann D, Carrington M, Clerici M, Shearer GM, Carbone DP, Scott DR, Houghten RA, Berzofsky JA. Tsukui T, et al. Among authors: carrington m. Cancer Res. 1996 Sep 1;56(17):3967-74. Cancer Res. 1996. PMID: 8752165
Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
Hildesheim A, Schiffman M, Scott DR, Marti D, Kissner T, Sherman ME, Glass AG, Manos MM, Lorincz AT, Kurman RJ, Buckland J, Rush BB, Carrington M. Hildesheim A, et al. Among authors: carrington m. Cancer Epidemiol Biomarkers Prev. 1998 Nov;7(11):1035-41. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9829713
Genetic acceleration of AIDS progression by a promoter variant of CCR5.
Martin MP, Dean M, Smith MW, Winkler C, Gerrard B, Michael NL, Lee B, Doms RW, Margolick J, Buchbinder S, Goedert JJ, O'Brien TR, Hilgartner MW, Vlahov D, O'Brien SJ, Carrington M. Martin MP, et al. Among authors: carrington m. Science. 1998 Dec 4;282(5395):1907-11. doi: 10.1126/science.282.5395.1907. Science. 1998. PMID: 9836644
p53 polymorphism and risk of cervical cancer.
Hildesheim A, Schiffman M, Brinton LA, Fraumeni JF Jr, Herrero R, Bratti MC, Schwartz P, Mortel R, Barnes W, Greenberg M, McGowan L, Scott DR, Martin M, Herrera JE, Carrington M. Hildesheim A, et al. Among authors: carrington m. Nature. 1998 Dec 10;396(6711):531-2. doi: 10.1038/25040. Nature. 1998. PMID: 9859989 No abstract available.
HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.
Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, Goedert JJ, Kaslow R, Buchbinder S, Hoots K, O'Brien SJ. Carrington M, et al. Science. 1999 Mar 12;283(5408):1748-52. doi: 10.1126/science.283.5408.1748. Science. 1999. PMID: 10073943
817 results